We describe a novel Fc 
INTRODUCTION
Fc fusion proteins are a popular means of producing eukaryotic receptors and extracellular molecules (2) . They are most commonly structured like IgG antibodies, in which the variable regions are replaced by a protein sequence of interest. The Fc region of these molecules serves as a tag for affinity purification and immunostaining and also confers a bivalent structure.
While the Fc region confers several useful properties to these fusion proteins, its presence can sometimes be problematic. In vivo, the bioavailability of Fc fusion proteins can theoretically be lowered by the Fc region, through binding of the proteins to cell surface Fc receptors. The branched, bivalent structure imposed by the Fc region complicates the use of Fc fusion proteins for structural analysis via electron microscopy or X-ray crystallography. Furthermore, the Fc region can sometimes reduce biological activity (3) .
We were concerned with this possibility recently while conducting a structure-function analysis of the cell adhesion molecule L1 (4) . The extracellular region of L1 can mediate several biological processes in the vertebrate nervous system, such as neurite outgrowth. We found that an Fc fusion protein containing the six Ig domains of L1 possessed neurite outgrowth activity at levels comparable to the native molecule, while fusion proteins containing fewer Ig domains were less active (4). While these results suggested that the six Ig domains of L1 were a functional unit, we could not exclude the possibility that the Fc region exerted an artifactual, negative influence on the shorter Fc fusion proteins, leading to a false-negative result.
Therefore, it was of value to analyze L1 fragments contained in our Fc fusion proteins without the presence of the Fc. Rather than resort to a different means of protein production, we designed a cleavable Fc fusion protein system in which the Fc region can be removed by tobacco etch virus (TEV) protease (8, 9) . TEV protease is a commercially available enzyme that is advantageous because of its high specificity for a seven amino acid recognition sequence and its activity at 4°C (9) . It has been used successfully to remove other types of fusion tags, such as glutathione-S-transferase (GST) and poly-histidine (7, 8, 10) . To verify our earlier findings, we made two TEV-Fc fusion proteins containing the six Ig domains of human L1 (that was previously found to be bioactive) and the first three Ig domains (that was found to be inactive) (4) . Cleavage of these TEV-Fc fusion proteins with TEV protease was then done to obtain L1 fragments in absence of the Fc. Finally, these fragments were assayed for neurite outgrowth activity, and the results confirmed our previous analysis of L1. These results demonstrated the usefulness of TEV-Fc fusion proteins for this and other applications.
MATERIALS AND METHODS

Construction of TEV-Fc Plasmids
The plasmid pCR/TEV-Fc was derived from the expression construct pCR/Fc (4), which contains a human IgG cDNA cloned into pCR3.1 (Invitrogen, Carlsbad, CA, USA). A doublestranded oligonucleotide encoding the TEV protease cleavage site was made by annealing the oligonucleotides 5 ′ -GATCCCGAGAACCTGTACTTCCA -GGGTACCGAA-3 ′ (TEV_Sense) and 5 ′ -GATCTTCGGTACCCTGGAAGT -ACAGGTTCTCGG-3 ′ (TEV_Anti -sense). This was phosphorylated with polynucleotide kinase and ligated into pCR/Fc cut with BamHI. Clones containing the insert were identified by Kpn I/ Stu I double digest, and the orientation was confirmed by sequencing. To construct L1-TEV-Fc expressing plasmids, PCR products encoding the first three (L1-13) or all six Ig domains (L1-16) of human L1 were produced with PfuDNA polymerase (Stratagene, La Jolla, CA, USA) as described previously (4). The PCR products were digested with Eco RI and Bcl I and ligated into pCR/TEV-Fc that was cut with Eco RI and BamHI. Finally, positive clones were identified by Hin dIII digests. The resultant plasmids were called pCR/L1-13TEV-Fc and pCR/L1-16TEV-Fc.
Protein Production
HEK 293 cells were transfected with pCR/L1-13TEV-Fc or pCR/L1-16TEV-Fc, and stable clones were isolated by selection with 1 mg/mL effective G418 (Life Technologies, Rockville, MD, USA). Cell lines that highly express L1-13TEV-Fc or L1-16TEV-Fc were identified by ELISA. These were passaged into 15-cm tissue culture plates (Falcon, Lincoln Park, NJ, USA) and cultured in DMEM, 10% IgG-depleted fetal calm serum (FCS) (Life Technologies), 2 mM l-Gln, 55 µ g/mL gentamicin. Note that IgG-depleted FCS was used to avoid contamination of Fc fusion protein preparations with bovine Igs (that are abundant in standard FCS). At one-week intervals, the media was collected and the cells were refed; such terminal cultures typically lasted for four weeks. Cultured supernatants containing Fc fusion protein were spun at 4500 ×gfor 15 min and decanted to remove cellular debris. The protein in the supernatant was then precipitated by addition of 390 g/L ammonium sulfate (Sigma, St. Louis, MO, USA). The precipitate was collected by centrifugation at 1 0 000 ×g for 15 min at 4°C, resuspended in PBS (40 mL/L cultured supernatant) and then dialyzed against 50 volumes PBS with three changes. Finally, the amount of Fc fusio n protein/mL ammonium sulfate dialysate was determined by immunoprecipitation of 1 mL of the dialysate with 30 µ L protein-A Seph arose ® slurry (Pierce Chemical, Rockford, IL, USA). To purify L1-13TEV-Fc and L1-16TEV-Fc, ammonium sulfate dialysates were incubated with protein-A Sepharose, and the proteins were eluted with 100 mM glycine, pH 2.8, as described for other Fc fusion proteins (11) . Typical yields were 1-3 mg/L cultured supernatant.
Cleavage of TEV-Fc Fusion Proteins
After ammonium sulfate precipitation and dialysis, preparations of L1-13TEV-Fc or L1-16TEV-Fc were incubated with protein-A Sepharose beads (150 µ L packed beads/50 mL dialysate) in a 50-mL conical tube (Falcon) at 4°C overnight. The beads were then washed twice with 10 mL 6 × PBS, 0.1% Triton ® X-100, twice with 10 mL 1 × PBS, 0.5% Triton X-100, and four times with 10 mL PBS. The beads were resuspended in 0.5-1 mL PBS and transferred to a 1.5-mL centrifuge tube. TEV protease (Life Technologies) was then added, and the slurry was incubated with rocking at 4°C for 6-21 h. It was determined that 0.25 U protease/ µ g TEV-Fc fusion protein is optimal for efficient cleavage under these conditions (data not shown). Equal aliquots of slurry were collected and analyzed on SDS-PAGE gels stained with SYPRO ® Orange (Molecular Probes, Eugene, OR, USA) to measure cleavage efficiency. The cleavage reaction supernatant, containing the cleavage product, was separated from the beads by passing the slurry through a disposable plastic column (Bio-Rad Laboratories, Hercules, CA, USA). The protein concentration was measured using Bradford assay (Bio-Rad Laboratories), and the purity was assessed by SDS-PAGE gels stained with SYPRO Orange. Finally, the proteins were analyzed via western blot with anti-human Fc antibody (Jackson ImmunoResearch, West Grove, PA, USA) or with Neuro 4.1, a monoclonal antibody specific for human L1 (12) .
Removal of TEV Protease
To moved by centrifugation, and the supernatant, containing the cleavage product, was collected. To verify removal of the protease, equivalent aliquots, obtained before and after addition of the metal affinity resin, were analyzed via SDS-PAGE.
Reaggregate Neurite Outgrowth Assay
Reaggregate neurite outgrowth was done essentially as described (4) . Briefly, P0-P4 mouse cerebellar reaggregates were plated on polystyrene dishes (Falcon) coated with 10 µ g/mL poly-l-lysine (Sigma) and 0-600 nM L1-TEV-Fcs or L1 cleavage products. After 16 h incubation, the length of the tenth longest neurite of each reaggregate was measured using NIH Image software as described (4).
RESULTS AND DISCUSSION
To produce TEV-Fc fusion proteins, the expression construct pCR/TEV-Fc was made ( Figure 1A ). This plasmid encodes the Fc region of human IgG fused to a sequence containing the TEV protease site. Using this plasmid, two TEV-Fc fusion proteins were generated: L1-16TEV-Fc, which contains all six Ig domains of human L1, and L1-13TEV-Fc, which contains the first three Ig domains ( Figure 1B) . The TEV protease site resides in the "hinge" region of the proteins, between the L1 and Fc sequences. L1-16TEV-Fc and L1-13TEV-Fc migrated at approximately 140 and 90 kDa, respectively, and were recognized by anti-human L1 and anti-human Fc antibodies (Figure 2 and data not shown).
A purification and cleavage method for L1-16TEV-Fc and L1-13TEV-Fc was devised. The proteins were absorbed to protein-A Sepharose beads, and the beads were washed with PBS to remove unbound contaminants. TEV protease was then added to the slurry, and the reaction was incubated at 4°C under agitation. After 6 h, a significant amount of cleavage was observed when analyzed by SDS-PAGE (Figure 2 ). L1-16TEV-Fc was cleaved into two bands of approximately 110 and 30 kDa that were identified by western blot as the L1-16 fragment and the Fc region, respectively ( Figure 2, A and B) . The Fc region remained bound to the protein-A beads, while the L1-16 fragment was liberated into the reaction supernatant ( Figure 2B) . A minor fraction of L1-16TEV-Fc (about 10%) appeared to be resistant to cleavage. However, minimizing the amount of protein-A beads used to absorb the Fc fusion protein could reduce this population (data not shown). This observation suggests that some protein binding sites on or within the protein-A beads are inaccessible to the protease.
L1-13TEV-Fc was also efficiently cleaved by TEV protease. The intact fusion protein, which migrated at about 90 kDa, was cleaved into two bands of approximately 55 and 30 kDa ( Figure  2C ). The heavier band was confirmed to be the L1-13 fragment by western blot, and the 30-kDa band was shown to be the Fc fragment (data not shown). In contrast to L1-16, some degradation of L1-13 was evident in SDS-PAGE gels and western blots of the cleavage reaction ( Figure 2C and data not shown) . It is possible that the L1-13 fragment may be intrinsically labile without the Fc, which is known to have a stabilizing influence on some proteins (2). For L1-13, the ability to conduct cleavage reactions at 4°C was highly advantageous, as this temperature appeared to improve its stability (data not shown).
To remove TEV protease from protein preparations, we took advantage of a poly-histidine tag that is present on the commercially available enzyme (8) . A short incubation with metal affinity resin removed TEV protease from the cleavShort Technical Reports age reaction supernatants ( Figure 2D ). Therefore, highly pure L1 fragments were obtained by cleavage of TEV-Fc fusion proteins with TEV protease. The neurite outgrowth activity of L1-16 and L1-13 was then assessed. For comparison, uncleaved L1-16TEV-Fc and L1-13TEV-Fc were tested in parallel. It was found that L1-16 strongly promoted neurite outgrowth, similar to L1-16TEV-Fc (Figure 3) . Furthermore, L1-16 and L1-16TEV-Fc had similar potencies in this assay, as they were both active at concentrations as low as 22 nM (data not shown). In contrast, neither L1-13 nor L1-13TEV-Fc promoted neurite outgrowth at concentrations as high as 600 nM ( Figure 3 and data not shown). These results show that the inactivity of L1-13TEV-Fc was not due to artifactual effects of the Fc region. Instead, it is likely that additional L1 domains are necessary for neurite outgrowth activity, as was previously theorized (4).
The TEV-Fc fusion protein system yields highly pure monomeric proteins that are soluble in PBS. For many biological applications, these proteins are ready-to-use without further isolation or dialysis. The process is efficient as well as scalable: we have obtained yields as high as 2 mg/L cultured supernatant, with 90% cleavage efficiency, from individual L1-16 preparations ( Figure 3E and data not shown) . This is significant because certain protein-intensive tasks, such as X-ray crystallography or animal studies, require large quantities of homogenous proteins. Therefore, several useful applications of the TEV-Fc fusion protein system can be envisioned.
It should be noted that other cleavable Fc fusion proteins have been described, in which the Fc region can be removed by thrombin (5, 6) or subtilisin BPN′ (1). However, the TEV-Fc system has several advantages, owing to the unique properties of TEV protease. First, the TEV protease cleavage site is longer (seven residues) and, hence, likely to be more specific than that of thrombin (four residues) or subtilisin (six residues). Second, cleavage of TEV-Fc fusion proteins can be conducted at 4°C (as opposed to 25°C or 37°C), a temperature that preserves the stability of many proteins. Finally, commercially available TEV protease can be easily removed from protein preparations via its poly-histidine tag (8) . Therefore, the TEV-Fc fusion protein system may be preferable to other cleavable Fc fusion proteins in certain situations. It is likely that TEV-Fc fusion proteins will further enhance the utility of this class of molecules for scientific and clinical applications. 
